Luis M Esteban
Overview
Explore the profile of Luis M Esteban including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
37
Citations
422
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Morote J, Borque-Fernando A, Esteban L, Picola N, Munoz-Rodriguez J, Paesano N, et al.
World J Urol
. 2024 Jul;
42(1):393.
PMID: 38985325
Purpose: To validate the Barcelona-magnetic resonance imaging predictive model (BCN-MRI PM) for clinically significant prostate cancer (csPCa) in Catalonia, a Spanish region with 7.9 million inhabitants. Additionally, the BCN-MRI PM...
2.
Morote J, Borque-Fernando A, Esteban L, Celma A, Campistol M, Miro B, et al.
J Pers Med
. 2024 Feb;
14(2).
PMID: 38392564
Risk-stratified pathways (RSPs) are recommended by the European Association of Uro-logy (EAU) to improve the early detection of clinically significant prostate cancer (csPCa). RSPs can reduce magnetic resonance imaging (MRI)...
3.
Morote J, Borque-Fernando A, Triquell M, Campistol M, Servian P, Abascal J, et al.
Eur Urol Open Sci
. 2023 Jul;
53:46-54.
PMID: 37441350
Background: Magnetic resonance imaging (MRI)-based risk calculators (MRI-RCs) individualise the likelihood of clinically significant prostate cancer (csPCa) and improve candidate selection for prostate biopsy beyond the Prostate Imaging Reporting and...
4.
Morote J, Borque-Fernando A, Triquell M, Abascal J, Servian P, Planas J, et al.
BJUI Compass
. 2023 Jun;
4(4):420-422.
PMID: 37334020
No abstract available.
5.
Morote J, Borque-Fernando A, Triquell M, Campistol M, Celma A, Regis L, et al.
Cancers (Basel)
. 2022 Oct;
14(20).
PMID: 36291883
A predictive model including age, PCa family history, biopsy status (initial vs repeat), DRE (normal vs abnormal), serum prostate-specific antigen (PSA), and DRE prostate volume ca-tegory was developed to stratify...
6.
Salesa A, Esteban L, Lopez-Julian P, Perez-Benedicto J, Acero-Oliete A, Pons-Ruiz A
Materials (Basel)
. 2022 Aug;
15(16).
PMID: 36013850
The construction industry must meet current environmental requirements, mostly those pertaining to the reduction in construction and demolition waste and the consumption of raw materials. The use of recycled concrete...
7.
Morote J, Borque-Fernando A, Triquell M, Esteban L, Trilla E
Eur Urol Open Sci
. 2022 Jul;
42:40-41.
PMID: 35795075
No abstract available.
8.
Morote J, Borque-Fernando A, Triquell M, Celma A, Regis L, Mast R, et al.
Cancers (Basel)
. 2022 May;
14(10).
PMID: 35625978
This study is a head-to-head comparison between mPSAD and MRI-PMbdex. The MRI-PMbdex was created from 2432 men with suspected PCa; this cohort comprised the development and external validation cohorts of...
9.
Serrano M, Sabroso S, Esteban L, Berenguer M, Fondevila C, Lorente S, et al.
Transpl Int
. 2022 May;
35:10263.
PMID: 35615539
In the last few years, several studies have analyzed sex and gender differences in liver transplantation (LT), but none have performed a disaggregated analysis of both mortality and causes of...
10.
Morote J, Borque-Fernando A, Triquell M, Celma A, Regis L, Mast R, et al.
Cancers (Basel)
. 2022 Apr;
14(7).
PMID: 35406600
We sought to find further evidence showing the increase in PCa aggressiveness as PI-RADS score increases from four surrogates of PCa aggressiveness: i. prostate biopsy GG (≤3 vs. >3), ii....